National and Location-Specific Medicare Physician Fee Reimbursement Trends in Urologic Oncology From 2002 to 2024
Inflation-adjusted Medicare physician reimbursement has been declining for all urologic oncology procedures over the past 2 decades, with more substantial declines noted in recent years. As key stakeholders, urologists must remain active in policy decisions pertaining to physician reimbursement.
Authors
- Kyle J. Kopechek (ORCID: https://orcid.org/0000-0003-2727-4338)
- Matthew Satariano
- Shawn Dason (ORCID: https://orcid.org/0000-0002-9247-7687)
- Tasha Posid (ORCID: https://orcid.org/0000-0002-2943-2726)
Institutions
- The Ohio State University Wexner Medical Center (US)
- Northeast Ohio Medical University (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/upj.0000000000000795
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00